Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $39.00 Average Price Target from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been given a consensus recommendation of “Moderate Buy” by the thirteen ratings firms that are covering the stock, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $39.00.

Several research firms have recently weighed in on ACHC. UBS Group dropped their target price on shares of Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Raymond James Financial reissued an “outperform” rating and issued a $26.00 target price (down previously from $40.00) on shares of Acadia Healthcare in a research report on Thursday, August 14th. Royal Bank Of Canada decreased their price target on shares of Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. Wall Street Zen raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Sunday, August 3rd. Finally, Barclays decreased their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating for the company in a report on Thursday, August 7th.

Acadia Healthcare Price Performance

ACHC opened at $26.62 on Friday. The company has a 50-day moving average of $22.16 and a 200-day moving average of $23.55. The company has a market capitalization of $2.46 billion, a P/E ratio of 17.63, a PEG ratio of 4.83 and a beta of 0.90. Acadia Healthcare has a 1-year low of $17.13 and a 1-year high of $60.52. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Equities analysts expect that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Verdence Capital Advisors LLC increased its position in shares of Acadia Healthcare by 3.3% during the 2nd quarter. Verdence Capital Advisors LLC now owns 14,656 shares of the company’s stock worth $333,000 after purchasing an additional 465 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. PNC Financial Services Group Inc. increased its position in Acadia Healthcare by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock valued at $202,000 after acquiring an additional 622 shares in the last quarter. LPL Financial LLC increased its position in Acadia Healthcare by 1.2% in the 1st quarter. LPL Financial LLC now owns 56,527 shares of the company’s stock valued at $1,651,000 after acquiring an additional 697 shares in the last quarter. Finally, UMB Bank n.a. increased its position in Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company’s stock valued at $38,000 after acquiring an additional 755 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.